Floatz logo

Acellular Pertussis Vaccine

Advanced Ovarian Carcinoma

Mayo ClinicPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

31 Active assets in the Advanced Ovarian Carcinoma cohort.

Asset / SponsorPhaseRating
Irinotecan
OHSU Knight Cancer Institute
Phase 2BB
Capecitabine
OHSU Knight Cancer Institute
Phase 3BB
TAMOXIFEN
OHSU Knight Cancer Institute
Phase 3BB
Bms-907351
M.D. Anderson Cancer Center
Phase 2BB
Abemaciclib
OHSU Knight Cancer Institute
Phase 2BB

View all 33 →

Same molecule, other indications

Acellular Pertussis Vaccine is also rated in:

Advanced Fallopian Tube High Grade Serous AdenocarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
Advanced Fallopian Tube CarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
Advanced Ovarian CarcinosarcomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →